Star Lake Bioscience Co (SHSE:600866) Total Liabilities : ¥6,752 Mil (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Total Liabilities?

Star Lake Bioscience Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥6,752 Mil.

Star Lake Bioscience Co's quarterly Total Liabilities increased from Sep. 2023 (¥6,300.70 Mil) to Dec. 2023 (¥6,725.18 Mil) and increased from Dec. 2023 (¥6,725.18 Mil) to Mar. 2024 (¥6,751.99 Mil).

Star Lake Bioscience Co's annual Total Liabilities increased from Dec. 2021 (¥8,941.48 Mil) to Dec. 2022 (¥9,070.20 Mil) but then declined from Dec. 2022 (¥9,070.20 Mil) to Dec. 2023 (¥6,725.18 Mil).

Star Lake Bioscience Co Total Liabilities Historical Data

The historical data trend for Star Lake Bioscience Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Total Liabilities Chart

Star Lake Bioscience Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

595.95

752.97

8,941.48

9,070.20

6,725.18

Star Lake Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															9,509.74	7,533.06	6,300.70	6,725.18	6,751.99

Star Lake Bioscience Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Star Lake Bioscience Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4630.234	+	(1760.667	+	334.278
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	6,725

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	14384.586	-	7659.407
	=	6,725

Star Lake Bioscience Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4819.85	+	(1705.445	+	226.693
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	6,752

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	14687.215	-	7935.226
	=	6,752

Star Lake Bioscience Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Lake Bioscience Co (SHSE:600866) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060

Website

http://www.starlake.com.cn

Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines